Raphael Nir
Co-Founder, President and CSO at SBH Sciences | Greater Boston
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Dr. Raphael Nir is a distinguished scientist and entrepreneur with over three decades of experience in the biotechnology sector, particularly in the commercialization of recombinant cytokines and preclinical contract research services. As the Co-Founder, President, and Chief Scientific Officer of SBH Sciences, Dr. Nir plays a pivotal role in steering the company’s innovative discovery programs for both small and large molecules. Under his leadership, SBH Sciences has established itself as a key player in the biotechnology landscape, providing comprehensive preclinical process development services tailored to the needs of the biopharmaceutical, diagnostics, and biotechnology industries.
Dr. Nir’s expertise spans a wide array of disciplines, including cell biology, molecular biology, and assay development, making him a sought-after thought leader in the field. His work at SBH Sciences involves overseeing advanced cell culture techniques, including mammalian and insect cell systems, as well as customized protein purification processes. These capabilities are critical for the development of cell-based assays, which are essential for evaluating the efficacy and safety of new therapeutics. Additionally, Dr. Nir’s commitment to innovation is evident in his involvement in key projects that leverage cutting-edge technologies to accelerate drug discovery and development.
Beyond his role at SBH Sciences, Dr. Nir has co-founded several biotech companies, including Karyopharm Therapeutics and Galectin Sciences, further showcasing his entrepreneurial spirit and dedication to advancing life sciences. His extensive background in the pharmaceutical industry, combined with his skills in microbiology and cancer research, positions him as a leading figure in the ongoing quest to develop novel therapeutics that address unmet medical needs. Through his work, Dr. Nir continues to contribute significantly to the advancement of biotechnology, fostering collaborations that drive scientific discovery and improve patient outcomes.
Co-Founder, President and CSO at SBH Diagnostics in January 2013 to Present
Co-Founder, President and CSO at SBH Sciences in September 1997 to Present
Co-Founder and Managing Partner at ABI - LAB in February 2016 to Present
Co-Founder, Preclinical Development Consultant at Vuja De Sciences in November 2017 to Present
Co-Founder and Board Member at NeuroDex in August 2018 to Present
Co-Founder at Alma Bio Therapeutics in May 2014 to May 2022
Co-Founder and Partner at Sky Ventures in August 2014 to December 2016
Senior Scientist / Associate Principal Scientist at Schering-Plough in January 1992 to January 1997
Post Doc. at Schering-Plough Research Institute in January 1990 to January 1992
See more
See less
Biotechnology
Cell Culture
Biochemistry
Drug Discovery
Cell Biology
Lifesciences
Molecular Biology
ELISA
Assay Development
Cell
Protein Purification
Biopharmaceuticals
Technology Transfer
Pharmaceutical Industry
Microbiology
Protein Chemistry
Commercialization
Biomarker Discovery
Hardware Diagnostics
Clinical Development
Science
Immunology
Monoclonal Antibodies
Drug Development
Cancer
Protein Expression
Biomarkers
Life Sciences
R&D
Research and Development (R&D)
See more
See less
Discover more about SBH SciencesWhat is Raphael Nir email address?
Email Raphael Nir at [email protected] and [email protected]. This email is the most updated Raphael Nir email found in 2026.
What is Raphael Nir phone number?
Raphael Nir phone number is +16177210785 and +16176808195.
How to contact Raphael Nir?
To contact Raphael Nir send an email to [email protected] or [email protected]. If you want to call Raphael Nir try calling on +16177210785 and +16176808195. (updated on September 13, 2024)
What is Raphael Nir net worth?
Raphael Nir has an estimated net worth of $750,000 to $999,999
What company does Raphael Nir work for?
Raphael Nir works for SBH Sciences
What is Raphael Nir's role at SBH Sciences?
Raphael Nir is Co-Founder, President and CSO
What industry does Raphael Nir work in?
Raphael Nir works in the Biotechnology Research industry.
Raphael Nir Email Addresses
Raphael Nir Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Raphael Nir
Director of Behavioral Health Services at Round Rock ISD
Print Operations. Senior Director, Large Format and 3D Supply Chain Operations at HP at HP
President at A'B'C
Founded | CEO at Phocal Productions
Administrative Assistant at Rutland Dundee Fire Protection District
Sr. Technical Recruiter at Navatech Inc
Retail General Manager at Royal Farms
Founder & Director at Art For Art
Executive Assistant at PDC BRANDS
Freelance Graphic Designer at J.J.Nelms Designs
Special Education Coordinator at Invictus Preparatory Charter School
Store Manager at Delaware North
Hospitality and Sales at Law Estate Wines
Owner at Suncoast Restoration Services Inc.
Field Service, Sales Support -RPOC at Weatherford International
Vice President of Sales at Hines Precision Inc.
Financial Reporting Analyst at Costco Wholesale
Region Vice President - Engineering, Network Maintenance, & Construction at Comcast
Researcher - Stanford Integrative Mental Health Laboratory at Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine
Program Manager at Sierra Nevada Corporation
Managing Director, Head of Global Technology Infrastructure and Operations at Sculptor Capital Management
Postgraduate Researcher at RCSI Tissue Engineering Research Group (TERG)
Manager at Atlas Cut Stone Inc.
Show more
Show less